Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace

Continue ReadingAllergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

Clinical-Stage Biotech Stock Might Outperform Amgen

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

This biotech could potentially could be a better value. Source: BioSpace

Continue ReadingClinical-Stage Biotech Stock Might Outperform Amgen

Teva's CGRP Migraine Med Hits a Stumbling Block

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

It's start­ing to feel like Teva can't catch a break. Source: BioSpace

Continue ReadingTeva's CGRP Migraine Med Hits a Stumbling Block

Teva Continues Restructuring With 46 Cuts in Pennsylvania

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace

Continue ReadingTeva Continues Restructuring With 46 Cuts in Pennsylvania

Sanofi Abandons Multiple Mid-Stage Drug Programs

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace

Continue ReadingSanofi Abandons Multiple Mid-Stage Drug Programs

Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace

Continue ReadingArbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility

Amicus Releases More Impressive Pompe Disease Data at WORLDSymposium

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace

Continue ReadingAmicus Releases More Impressive Pompe Disease Data at WORLDSymposium

Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace

Continue ReadingGilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

Interview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace

Continue ReadingInterview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace

Continue ReadingMadrigal's Cholesterol Drug Succeeds in Mid-Stage Trial
  • Go to the previous page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.